RecallGuardianCanada
Drugs· Type I· Updated July 8, 2025

NRA-AMLODIPINE 5MG: Affected lot may contain tablet(s) of Metoprolol Succinate prolonged–release 12.5 mg tablets

Critical priority
What you should do
  1. 1Check your medication bottle to ensure it only contains NRA-AMLODIPINE 5 mg tablets.
  2. 2If your bottle contains any round tablets, which are not the correct shape, or if you're unsure, return the bottle to your pharmacy for a replacement.
  3. 3If you are unable to get a replacement immediately, continue to take your medication as directed, but do not take the round tablets as these are the wrong medication.
  4. 4Contact your health care professional if you are dizzy, have unusually low blood pressure or slow heartbeats.
  5. 5If you are unable to access a health care professional and you are experiencing these symptoms, call 911.
The issue

Product safety

Affected product

NRA-AMLODIPINE 5MG

Where it was sold

Canada (national)Reported in the official notice — confirm there.

Issued by

Health Canada — Drugs and health products

Read the official Government of Canada notice

RecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.

All recalls